Charles (Chuck) V. Clevenger, M.D., Ph.D.
Charles (Chuck) V. Clevenger, M.D., Ph.D., has been named the incoming Chair of the Department of Pathology. Jerome F. Strauss, III, M.D., Ph.D., announced the appointment, noting that Clevenger will assume the position on July 1, 2013, and will begin his transition in a series of visits over the coming months.
Clevenger is currently the Diana, Princess of Wales Professor of Cancer Research in the Department of Pathology at Northwestern University, where he leads a vigorous NIH-funded translational research program on breast cancer. He is credited with major discoveries on the role of prolactin signaling in mammary cancers and has brought forward innovative therapeutic approaches based on his research. At Northwestern, he has served as co-leader of the Avon Foundation Breast Cancer Research Laboratories and the leader of the Women’s Cancer Research Program.
Clevenger currently serves as a member of the editorial board for Breast Disease and formerly served on the editorial boards of Endocrinology and the Journal of Histochemistry and Cytochemistry. He has received awards from the American Society for Clinical Investigation and the Pfizer Outstanding Investigator Award from the American Society for Investigative Pathology among others.
David S. Wilkinson, M.D., Ph.D.
Clevenger earned his B.S., M.D. and Ph.D. in tumor cell biology program from Northwestern. He completed his residency training in the Department of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania as well as fellowship training in cytopathology.
Since 1993, David S. Wilkinson, M.D., Ph.D., has led the Department of Pathology as professor and chair. While research indicates the average tenure of a U.S. Department Chair is about 8 years, Wilkinson has served a remarkable 20 years. Under his leadership, the department has been reputed for its clinical excellence and pioneering work in molecular diagnostics.